-
admin
Posts
WAISL Launches State-of-the-Art Digital Twin-Powered Integrated Airport Predictive Operations Centre
CANBERRA, Australia, Dec. 19, 2024 /PRNewswire/ — WAISL is delighted to announce the launch of its Digital Twin-Powered Integrated Airport Predictive Operations Centre (APOC) at...
TheLotter Australia: Celebrate the Holiday Season with an Immense Mega Millions Jackpot!
Your ticket to the world’s largest lottery jackpots – now in Australia. SYDNEY, Dec. 19, 2024 /PRNewswire/ — Get ready for a holiday miracle! The...
WAISL Unveils Advanced Digital Twin-Powered Integrated Airport Predictive Operations Centre
WELLINGTON, New Zealand, Dec. 19, 2024 /PRNewswire/ — WAISL is delighted to announce the launch of its Digital Twin-Powered Integrated Airport Predictive Operations Centre (APOC)...
IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets
ROTTERDAM, The Netherlands (18 December 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution and formulation partner of speciality chemicals and ingredients, has...
Herbal Beauty Products Market Set to Reach USD 135,897.65 Million by 2034, Driven by Growing Demand for Natural, Sustainable Skincare Solutions | Future Market Insights, Inc.
The Japan herbal beauty product market is projected to register a CAGR of 11.0% through 2034. This growth is driven by increasing interest in Japanese...
NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology
NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology Results from the ESTABLISH1...
Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by...
Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)
MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a...
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease
CAMBRIDGE, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies...
Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement
Proposed Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi has recently completed an approximately $28...
